Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Hydroxychloroquine Sulfate CAS 747-36-4 Production and Supply Insights

Aug . 20, 2024 22:17 Back to list

Hydroxychloroquine Sulfate CAS 747-36-4 Production and Supply Insights



Understanding Hydroxychloroquine Sulfate CAS 747-36-4 and Its Production


Hydroxychloroquine sulfate, with the Chemical Abstracts Service (CAS) number 747-36-4, is an antimalarial medication that has gained significant attention in recent years for its potential applications in treating autoimmune diseases and viral infections

. Produced in pharmaceutical factories worldwide, this compound has demonstrated efficacy in managing conditions such as lupus and rheumatoid arthritis, and it has also been studied for its role in combating COVID-19.

The production of hydroxychloroquine sulfate begins with the synthesis of the active pharmaceutical ingredient (API). Pharmaceutical factories utilize strict guidelines and quality control measures to ensure that the drug is produced under optimal conditions. The manufacturing process involves various chemical reactions and purification steps that transform raw materials into a safe, effective form of the medication.


Quality assurance is critical in the production of hydroxychloroquine. Manufacturers must adhere to Good Manufacturing Practices (GMP) to ensure that the drug meets predefined standards for safety, efficacy, and quality. This includes comprehensive testing for impurities and consistency in formulation. Regular audits and inspections by regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), help uphold these standards and protect public health.


hydroxychloroquine sulfate cas747-36-4 factory

Hydroxychloroquine Sulfate CAS 747-36-4 Production and Supply Insights

The demand for hydroxychloroquine sulfate surged during the COVID-19 pandemic, as researchers and healthcare professionals explored its potential as a treatment option. While it was initially touted as a possible therapeutic agent against the virus, extensive clinical trials ultimately revealed mixed results regarding its effectiveness. Despite this, the increased attention led to a rise in production capacities at factories around the globe. Many manufacturers scaled up their operations to meet the escalating demand, ensuring a steady supply to healthcare providers and patients in need.


Furthermore, the global push for hydroxychloroquine sulfate has highlighted the importance of accessible medications. Pharmaceutical factories play a crucial role in ensuring that drugs are not only produced efficiently but also distributed effectively to various regions. Importantly, the factories must navigate complex regulatory environments that differ from country to country, which can impact the availability of the medication in certain markets.


Another significant aspect of hydroxychloroquine sulfate production is the environmental and ethical considerations associated with pharmaceutical manufacturing. Factories are increasingly focusing on sustainable practices, aiming to minimize waste and reduce their carbon footprint. The implementation of green chemistry principles and environmentally friendly processes during the production of hydroxychloroquine sulfate is vital to preserving ecological integrity while ensuring that patients receive their medications safely and responsibly.


In conclusion, hydroxychloroquine sulfate (CAS 747-36-4) remains an essential medication in the pharmaceutical landscape, particularly in the context of autoimmune disorders and viral infections. The production of this compound in factories around the world requires adherence to stringent quality and safety standards. As ongoing research continues to investigate its potential uses, the pharmaceutical industry must balance the demand for effective treatments with sustainable and ethical production practices. The journey of hydroxychloroquine sulfate from raw materials to patient administration is a testament to the complexities of modern pharmaceuticals and the vital role of manufacturing in public health.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish